10x Genomics Inc (NAS:TXG)
$ 24.01 -0.82 (-3.3%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.00 GF Score: 75/100

10X Genomics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 12:50PM GMT
Release Date Price: $49.63 (+3.40%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hi, everyone. Good morning. My name is Tejas Savant, I'm the Life Science Tools and Diagnostics analyst here at Morgan Stanley. It's my pleasure to host 10x Genomics. And speaking on behalf of the company, we are lucky to have Serge Saxonov, CEO; and Justin McAnear, CFO. Welcome, gents.

Before we get started, quickly important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So maybe, Serge, just to set the stage, so much has gone on over the last few months for 10x. What are some of the things you want to get across to the investor community? And what are you most proud of this year?

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Yes. There has been a busy year, busy last few years, I would

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot